Managing Director Md Monir Ahmed, Chairman Tahmina Begum, Executive Director Maqsood Ahmed, Director Operation Sadia Ahmed, Independent Director, Company Secretary, Chief Financial Officer of Asiatic Laboratories Limited and other officials were present on this occasion. To gain market share and to become a reputed pharmaceutical company in Bangladesh Asiatic Laboratories Limited is participating in the IPO for Tk95 crore subject to the approval of BSEC through the book building method. This means that the sales revenue will increase by 98% from the current sales revenue and the payback period is presumed 2.5 years. This is the best time to invest in Asiatic Laboratories Ltd. and we will be able to give our shareholders the right returns and start our next milestone in the capital market." Recently, the pharmaceutical market has great potential and is projected to become a $6 billion market by 2025, with 114% growth from 2019.

Source: Dhaka Tribune October 24, 2021 19:54 UTC